Aug 01, 2023 / NTS GMT
Presentation
Aug 01, 2023 / NTS GMT
=====================
Corporate Participants
=====================
* Claus Zieler
Astellas Pharma Inc. - Chief Commercial Officer
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Naoki Okamura
Astellas Pharma Inc. - President, CEO, CFO & Director
* Tadaaki Taniguchi
Astellas Pharma Inc. - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kasumi Haruta
Crédit Suisse AG, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Madoka Sato
Schroders plc - Analyst
* Naomi Kumagai
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division - Senior Analyst
* Shinichiro Muraoka
Astellas Pharma Inc
(OTCPK:ALPMY)
$
13.73
-0.69 (-4.79%)
Market Cap: 24.60 Bil
Enterprise Value: 26.29 Bil
PE Ratio: 12.80
PB Ratio: 2.21
GF Score: 81/100 Q1 2024 Astellas Pharma Inc Earnings Presentation Transcript
Aug 01, 2023 / NTS GMT
Release Date Price:
$14.47
(-1.09%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot